HOBOKEN, N.J., Nov. 4, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) yesterday cleared the way for the U.S. market return of octagam® [Immune Globulin Intravenous (human) 5% Liquid Preparation], the Octapharma USA product used to treat disorders of the immune system. In August ...
Related News:-
FDA Upd8
Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the ...
FDA Upd8
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION), announced today that the U.S. Food and Drug Administration ("FDA") had responded to its Special Protocol Assessment ("SPA ...
Biotechnology Buzz
Regenicin, Inc. (OTC Bulletin Board: WDST) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and ...
Health Upd8
The International Stroke Conference features more than 900 presentations on stroke science, and more than 3,500 attendees are expected. The American Stroke Association ...
No comments:
Post a Comment